FSD Pharma Inc.

HUGE · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$18,565-$26,704-$33,938-$28,452
Dep. & Amort.$2,506$4,535$4,046$3,900
Deferred Tax-$7,595$0-$1,206-$2,766
Stock-Based Comp.$3,835$1,531$7,444$8,052
Change in WC$1,668-$7,120$2,889$807
Other Non-Cash-$576-$575$20-$672
Operating Cash Flow-$11,026-$28,333-$20,746-$19,130
Investing Activities
PP&E Inv.$0-$364-$500$0
Net Acquisitions$32$0$769$0
Inv. Purchases-$745-$402$0$0
Inv. Sales/Matur.$443$158$0$6,478
Other Inv. Act.$32$12,731-$1$37
Investing Cash Flow-$270$12,123$269$6,514
Financing Activities
Debt Repay.-$189-$143-$129-$987
Stock Issued$0$0$38,341$25,100
Stock Repurch.-$2,958-$1,926$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$20$0$0$60
Financing Cash Flow-$3,127-$2,069$38,212$24,173
Forex Effect$0$0$0$0
Net Chg. in Cash-$14,223-$18,279$17,735$11,557
Supplemental Information
Beg. Cash$16,973$35,260$17,525$5,968
End Cash$2,757$16,980$35,260$17,525
Free Cash Flow-$10,827-$28,697-$21,246-$19,130